After the Australia-based company that provides personalized health care to smartphone users, announced its first partnership in the Middle East, the shares of Advanced Health Intelligence Ltd. , +132.43% soared 156.8%. Trading volume soared to 18,7 million shares – more than twice the average full-day trading volume of 8.1 millions shares. The company announced that it had signed a letter-of-intent (LOI), in which Pharmak Pharmacy LLC of Dubai will integrate Advanced Health’s Biometric Health Assessment to deliver its eScript offering to all Pharmak Partners. Pharmak expects to reach 100,000 e-script orders per month in the United Arab Emirates in 2024. The stock of Advanced Health was in the spotlight on Wall Street on June 9 when it surged 603.2% on volume of 130.8 millions shares, despite no news being reported and a company refusing to comment. By Tuesday, the stock fell 69.2% during a five-day loss streak. The stock has risen 80.5% in the past year, according to data through Tuesday.